Virotech Diagnostics

What Virotech Diagnostics does

Gold Standard Diagnostics Frankfurt GmbH, trading as Virotech Diagnostics, is a privately held German diagnostic solutions company founded in 1986, headquartered in Frankfurt (Germany) with 51-100 employees. The company develops, manufactures, and distributes in vitro diagnostic (IVD) products for clinical and veterinary laboratories across multiple testing methodologies, including chemiluminescence immunoassay (CLIA), ELISA, real-time PCR, Line Immunoblot, and Next-Generation Sequencing (NGS). Its flagship instrument, the Hurricane Dx fully automated random-access CLIA system, launched in 2026 with a 29-assay menu targeting autoimmune disease diagnostics and a stated expansion roadmap into infectious disease assays such as TORCH, EBV, and vaccine-preventable diseases. Additional specialty products include the MPLEX MPox/Orthopox/Clade 1B real-time PCR kit for emerging infectious disease detection, the Serazym Stool ELISA for gastrointestinal infections, the VetLine EHV1 ELISA for equine diagnostics, and disease-specific panels for arboviruses (Dengue, Zika, Chikungunya), Borrelia, and the M371-Test for testicular cancer.

The company's business model combines hardware sales of automated diagnostic platforms with recurring revenue from consumable reagents and assay kits across its installed base. Go-to-market is executed through a global network of distribution partners supplemented by direct event-driven engagement at major industry conferences (ESCMID 2026 in Munich, WHX Labs Dubai 2026, WHX Bangkok 2026) and a digital presence via the corporate website and LinkedIn. Primary customers are clinical and medical laboratories requiring broad test menus and automated throughput; veterinary laboratories form a secondary segment. Pricing is quote-based and not publicly disclosed, consistent with a B2B model serving enterprise laboratory buyers. The product portfolio is being expanded in 2026 with advanced molecular diagnostic solutions including NGS, positioning the firm to compete across both immunoassay and molecular diagnostic workflows.

Name

Virotech Diagnostics

Legal name

Gold Standard Diagnostics Frankfurt GmbH

Website

https://virotechdiagnostics.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

51–100 employees

Short description

Gold Standard Diagnostics Frankfurt GmbH (trading as Virotech Diagnostics) is a German IVD company founded in 1986 that develops and distributes diagnostic instruments and reagents across CLIA, ELISA, PCR, and NGS for clinical and veterinary laboratories worldwide.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics (Clinical Diagnostics)

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Clinical Chemistry & Immunoassay Systems (HLAHAAAA)

akta.pro secondary industries

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

• Clinical diagnostic reagents
• Immunoassay test kits
• Automated laboratory analyzers
• Molecular diagnostic PCR
• Autoimmune disease testing

Headquarters

HQ city

Rüsselsheim

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Diagnostic Instruments and Platforms: Sale of automated diagnostic platforms including the Hurricane Dx CLIA analyzer and other instrumentation for clinical laboratories.
2. Diagnostic Reagents and Assays: Sale of reagent kits and assay menus for various diagnostic methodologies including CLIA, ELISA, PCR, and Line Immunoblot tests. Includes ongoing consumable revenue from reagent sales.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Virotech Diagnostics (Gold Standard Diagnostics Frankfurt GmbH) develops, manufactures, and distributes in-vitro diagnostic instruments and reagent kits for clinical and veterinary laboratories. Its core portfolio spans chemiluminescence immunoassay (CLIA), ELISA, real-time PCR, and Line Immunoblot technologies, with the Hurricane Dx automated CLIA system as its flagship analyzer offering 29 autoimmune assays. The company also provides molecular diagnostic solutions including PCR kits (e.g., MPLEX MPOX/Orthopox/Clade 1B) and is expanding into Next-Generation Sequencing (NGS) and laboratory automation platforms.

Product overview

Gold Standard Diagnostics Frankfurt GmbH (trading as Virotech Diagnostics) offers a diversified portfolio of diagnostic solutions organized around multiple testing platforms. The core offering includes automated instrumentation platforms and reagents across several key technologies: CLIA (Chemiluminescence), ELISA, PCR (Real-Time), and Line Immunoblot. The flagship product is Hurricane Dx, a fully automated random-access CLIA system featuring 29 assays for autoimmune disease diagnostics. The company provides testing solutions across virology, bacteriology, parasitology, mycology, hormones, autoimmune diseases, oncology, and more recently, advanced molecular diagnostics including NGS. Specialized products include the MPLEX MPOX/ORTHOPOX/CLADE 1B real-time PCR assay, Serazym Stool ELISA for gastrointestinal infections, VetLine EHV1 ELISA for veterinary diagnostics, and disease-specific panels for Arboviruses (Dengue, Zika, Chikungunya) and Borrelia. The product portfolio is expanding in 2026 with advanced molecular diagnostic solutions.

Differentiator

Problem solved

Functional benefit

Brands

• Hurricane Dx: Fully automated random-access chemiluminescence (CLIA) system with a comprehensive assay menu featuring 29 assays for autoimmune disease diagnostics, with plans to expand to infectious diseases including TORCH, EBV, and vaccine preventable diseases
• Serazym
• VetLine
• MPLEX

Products and services

• Hurricane Dx™ CLIA Analyzer Fully automated random-access chemiluminescence (CLIA) analyzer with a comprehensive assay menu of reagents, featuring 29 assays for autoimmune disease diagnostics and planned expansion into infectious diseases. Designed for high-throughput clinical testing in clinical laboratories.
• MPLEX MPOX, ORTHOPOX, CLADE 1B Real-Time PCR Assay Real-Time PCR Assay (1 x 96 reactions) for the detection of mpox/orthopox viruses including the new clade 1b variant, intended for clinical laboratories performing molecular infectious disease diagnostics.
• Serazym Stool ELISA ELISA-based test for gastrointestinal infections (GI) with stool sample controls/standards (Serazym Stuhltest-Kontrollen), for clinical diagnostic laboratories performing gastrointestinal pathogen detection.
• VetLine EHV1 ELISA ELISA providing reliable diagnostic support for qualitative or semi-quantitative antibody detection of EHV1 (equine herpesvirus type 1) in equine serum, for veterinary diagnostic laboratories.
• Arboviruses Diagnostic Panel (Dengue, Zika, Chikungunya) Diagnostic solutions for arbovirus detection including Dengue, Zika, and Chikungunya, for clinical laboratories performing infectious disease serology.
• Borrelia Diagnostics Diagnostic solutions for Borrelia (Lyme disease) detection and monitoring, for clinical laboratories performing tick-borne disease diagnostics.
• M371-Test (Testicular Cancer Diagnostics) Specialized diagnostic test designed to optimize testicular cancer diagnostics, intended for clinical laboratories performing oncology testing.
• Molecular Diagnostic Solutions Portfolio (NGS and Automation) Advanced molecular diagnostic solutions portfolio including Next Generation Sequencing (NGS), automation systems, and real-time PCR kits for comprehensive molecular testing, intended for clinical laboratories performing molecular diagnostics.
• Automated Instrumentation Platforms Automated platforms for diagnostic testing including sample processing and analysis automation, supporting high-throughput clinical laboratory workflows.

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Global Distribution PartnerscoreChannel Partner/ Reseller/ DistributorCompany operates through a global network of distribution partners that enable international market coverage and customer reach across different geographic regions.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• DiaSorin: Italian specialty IVD company focused on chemiluminescence immunoassays (CLIA) and molecular diagnostics, with a strong autoimmune and infectious-disease menu. Closely comparable as a specialty immunoassay/molecular competitor to Hurricane Dx and the broader GSD portfolio.
• AESKU.GROUP: German-headquartered specialty diagnostics company with a broad autoimmune and infectious-disease portfolio spanning ELISA, immunofluorescence, and automated platforms. Comparable mid-sized German specialty IVD peer.
• Inova Diagnostics (Werfen): Specialty IVD company within the Werfen group focused on autoimmune disease diagnostics, including BIO-FLASH chemiluminescence and QUANTA Flash systems. A direct competitor to Hurricane Dx in the autoimmune CLIA segment.
• EUROIMMUN (PerkinElmer): German-headquartered autoimmune and infectious disease diagnostics specialist known for BIOCHIP and ELISA/immunoblot technologies. Directly comparable as a specialty autoimmune/serology IVD player operating from Germany.
• Sekisui Diagnostics: Specialty clinical chemistry, immunoassay, and coagulation diagnostics company with a multi-technology IVD portfolio. Comparable as a specialty IVD manufacturer with CLIA and rapid-test offerings serving clinical laboratories.
• Meridian Bioscience: US-headquartered specialty diagnostics company focused on immunoassay and molecular tests for infectious diseases. Comparable as a mid-sized specialty IVD player with similar infectious-disease and gastrointestinal test menus (e.g., Serazym Stool ELISA).

Broad incumbents

• Tecan: Swiss manufacturer of laboratory automation instruments and OEM immunoassay/molecular platforms. Comparable as a supplier of automated diagnostic instrumentation platforms that compete with Hurricane Dx-class analyzers.
• QIAGEN: Global molecular diagnostics and sample-preparation company with a broad PCR and NGS portfolio. Comparable as the company expands into real-time PCR kits, automation, and NGS in 2026.
• Bio-Rad Laboratories: Global life science and clinical diagnostics company with a substantial specialty IVD portfolio including immunoassays, autoimmune diagnostics, and quality controls — directly overlapping with Gold Standard Diagnostics' CLIA, ELISA, and autoimmune menu.
• Hologic: US-based molecular diagnostics and women's health company with Panther and Aptima systems. Relevant comparable for the company's emerging molecular diagnostics and infectious disease strategy (e.g., MPLEX MPOX assays).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks1 record

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/virotech-diagnostics

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Virotech Diagnostics